{"gene":"OCA2","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2001,"finding":"The OCA2/P protein localizes to the melanosome membrane and is required for normal melanosomal pH; melanosomes from p-deficient mouse melanocytes have non-acidic (rather than normal acidic) pH, suggesting OCA2 regulates melanosomal pH in conjunction with the ATP-driven proton pump, likely by transporting anions to compensate for proton charge.","method":"pH measurements in cultured melanocytes from p-deficient vs wild-type mice; subcellular fractionation and localization to melanosome membrane","journal":"Pigment cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct pH measurement in Oca2-null vs WT melanocytes, localization to melanosome membrane, single lab but multiple orthogonal observations","pmids":["11310796"],"is_preprint":false},{"year":1997,"finding":"Normal human P/OCA2 cDNA complements hypopigmentation in p-null mouse melanocytes, restoring melanin biosynthesis; OCA2 missense mutations (A481T, V443I) show minimal or partial complementation, establishing that OCA2 is directly required for melanin biosynthesis in melanocytes.","method":"Transfection of p-null melanocytes with wild-type and mutant human P cDNA; melanin content assay as functional readout","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution/complementation assay with mutagenesis, directly establishes OCA2 function and allele pathogenicity","pmids":["8980282"],"is_preprint":false},{"year":2008,"finding":"Endogenous OCA2 rapidly exits the ER and localizes to melanosomes in melanocytic cells (and to lysosomes in non-pigment cells). Melanosomal localization — not ER retention — is required for OCA2 function in melanin synthesis. A conserved N-terminal acidic dileucine motif is required for steady-state melanosomal localization; a second dileucine signal confers lysosomal localization. The two dileucine signals interact differentially with cytoplasmic adaptor proteins involved in melanosome trafficking.","method":"Live-cell imaging, subcellular fractionation, ER-retention mutagenesis rescue assays in OCA2-deficient melanocytes, mutagenesis of dileucine motifs, co-immunoprecipitation with adaptor proteins","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (localization, functional rescue with mutants, mutagenesis, adaptor binding), rigorous controls establishing subcellular localization tied to function","pmids":["19116314"],"is_preprint":false},{"year":2012,"finding":"Delivery of OCA2 to melanosomes requires both AP-3 and BLOC-1. AP-1 and AP-3 recognize the dileucine-based sorting signal of OCA2 based on primary sequence context, not position. AP-3 binding is necessary for steady-state melanosomal localization. Unlike tyrosinase (which uses AP-3 alone), both AP-1- and AP-3-favoring OCA2 variants require BLOC-1 for melanosomal transport, indicating BLOC-1 can cooperate with either adaptor during cargo sorting.","method":"Targeted mutagenesis of OCA2 dileucine sorting signal; functional complementation assays in OCA2-deficient cells; epistasis with AP-1, AP-3, BLOC-1 mutant cell lines; electron microscopy","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — mutagenesis combined with functional rescue, epistasis experiments with multiple adaptor-deficient lines, multiple orthogonal readouts","pmids":["22718909"],"is_preprint":false},{"year":2010,"finding":"Genetic epistasis experiments in mice show that BLOC-1 (pallid allele) is epistatic to OCA2 (pink-eyed dilution), and OCA2 deficiency acts as a semi-dominant enhancer of BLOC-2 (cocoa) and AP-3 (pearl) mutant phenotypes, establishing functional links between OCA2 and these three protein complexes in melanosome biogenesis.","method":"Double-mutant coat color epistasis analysis in C57BL/6J mice using pink-eyed dilution (Oca2), pallid (BLOC-1), cocoa (BLOC-2), and pearl (AP-3) alleles","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in vivo, single lab, well-controlled double-mutant phenotypes","pmids":["21392365"],"is_preprint":false},{"year":2008,"finding":"The HERC2 intron 86 SNP rs12913832 region acts as a regulatory element that significantly reduces OCA2 promoter activity; the two alleles bind different subsets of nuclear extracts, providing a cis-regulatory mechanism for allele-specific OCA2 expression.","method":"Luciferase reporter assay in cell cultures; electrophoretic mobility shift assay (EMSA)","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal in vitro methods (reporter assay + EMSA), single lab","pmids":["18172690"],"is_preprint":false},{"year":2012,"finding":"The HERC2 rs12913832 region functions as a long-range enhancer regulating OCA2 transcription. In darkly pigmented melanocytes (T allele), transcription factors HLTF, LEF1, and MITF bind this enhancer and a chromatin loop forms between the enhancer and the OCA2 promoter, leading to elevated OCA2 expression. In lightly pigmented melanocytes (C allele), chromatin-loop formation, TF recruitment, and OCA2 expression are all reduced.","method":"Chromatin immunoprecipitation (ChIP) for TF binding; chromosome conformation capture (3C) for chromatin looping; quantitative RT-PCR for OCA2 expression in darkly vs lightly pigmented human melanocytes","journal":"Genome research","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (ChIP, 3C, qRT-PCR) in primary human melanocytes, directly linking SNP allele to TF binding, chromatin looping and gene expression","pmids":["22234890"],"is_preprint":false},{"year":2013,"finding":"Loss of Oca2 in melanocytes leads to accumulation of tyrosinase in the ER, arrest of the unfolded protein response (UPR), and increased resistance to ER stress. In Oca2-null melanocytes, thapsigargin-induced ER stress triggers rapid eIF2α dephosphorylation (rather than phosphorylation) mediated by the Gadd34-PP1α phosphatase complex, suppressing pro-apoptotic PERK signaling and promoting cell survival.","method":"Thapsigargin treatment of Oca2-null vs wild-type melanocytes; immunoblotting for eIF2α phosphorylation, UPR markers; pharmacological inhibition of Gadd34-PP1α complex; cell viability assays","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined molecular phenotype, pharmacological rescue, multiple readouts; single lab","pmids":["23962237"],"is_preprint":false},{"year":2015,"finding":"siRNA-mediated knockdown of OCA2/P-protein in melan-a melanocytes significantly alters melanosomal morphology (size, shape, type, number) and reduces melanin content and tyrosinase-related protein levels, directly demonstrating OCA2's role in melanosome biogenesis.","method":"siRNA transfection of melan-a melanocytes, B16F10 and melan-p1 cells; transmission electron microscopy of melanosomes; melanin content and tyrosinase activity assays","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — siRNA KD with defined ultrastructural and biochemical phenotype, multiple cell lines, single lab","pmids":["25656818"],"is_preprint":false},{"year":2016,"finding":"TBX2 transcription factor represses OCA2 expression in melanocytes. α-MSH and forskolin reduce TBX2 expression while stimulating melanogenesis. TBX2 knockdown increases OCA2 expression and melanin production; combined knockdown of TBX2 and OCA2 blocks this effect. ChIP and reporter assays show TBX2 directly binds and represses the OCA2 promoter.","method":"siRNA knockdown of TBX2 in primary and immortalized mouse melanocytes; chromatin immunoprecipitation (ChIP); luciferase reporter assay; melanin content measurement","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP + reporter assay + genetic epistasis (double KD), single lab, two orthogonal methods","pmids":["26971330"],"is_preprint":false},{"year":2014,"finding":"OCA2 colocalized with LAMP2 (a lysosomal/late endosomal marker) and significantly with BLOC-1, but not with ER, Golgi, or melanosome markers, when examined with newly generated specific antibodies in human melanocytes and RPE cells.","method":"Immunohistochemistry and confocal microscopy with newly generated anti-P antibodies; co-localization with subcellular organelle markers","journal":"Journal of dermatological science","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single localization method, no functional consequence linked; partially contradicts other papers that show melanosomal localization","pmids":["25530116"],"is_preprint":false},{"year":2018,"finding":"CRISPR/Cas9-generated oca2 loss-of-function mutations in surface Astyanax mexicanus produce albinism due to disruption of the first step in melanin synthesis. Hybrid offspring from crosses of oca2-mutant surface fish with albino cavefish are albino, demonstrating that oca2 is solely responsible for albinism in multiple independently evolved cavefish populations.","method":"CRISPR/Cas9 mutagenesis in Astyanax mexicanus; genetic complementation test (cross between engineered surface mutants and cavefish)","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — CRISPR KO plus genetic complementation in vivo, directly establishes causal and exclusive role of oca2 in albinism","pmids":["29555241"],"is_preprint":false},{"year":2013,"finding":"Downregulation of oca2 expression in Astyanax surface fish embryos delays development of pigmented melanophores and simultaneously increases L-tyrosine and dopamine levels, demonstrating that OCA2 operates at the first step of the melanin synthesis pathway and that its loss diverts substrate (L-tyrosine) to catecholamine synthesis.","method":"Morpholino knockdown of oca2 in Astyanax surface fish embryos; HPLC measurement of L-tyrosine, dopamine, and norepinephrine; melanophore counting","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — morpholino KD with biochemical (HPLC) and cellular (melanophore) readouts in vivo, single lab","pmids":["24282555"],"is_preprint":false},{"year":2021,"finding":"oca2 has a pleiotropic role regulating both pigmentation and sleep. Surface Astyanax fish with engineered oca2 mutations show both albinism and reduced sleep. The oca2 mutation fails to complement sleep loss when oca2-mutant surface fish are crossed to independently evolved albino cavefish, establishing that oca2 is genetically responsible for sleep loss as well as albinism in cavefish.","method":"CRISPR/Cas9 oca2 mutagenesis; sleep quantification in F2 hybrid fish and oca2 surface mutants; genetic non-complementation test across cave populations; QTL co-segregation analysis","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — CRISPR KO combined with non-complementation genetics and QTL analysis, multiple independent approaches in same study","pmids":["34293332"],"is_preprint":false},{"year":2023,"finding":"Computational structural modeling (AlphaFold2) suggests OCA2 adopts a transporter fold similar to SLC13 family members (scaffold and transport domains with pseudo-inverted repeat topology including re-entrant loops), an elevator-type transport mechanism, and contains a cryptic GOLD domain likely responsible for ER-to-Golgi trafficking. Conserved asparagine residues in the putative ligand-binding site suggest OCA2 may function as a Na+/dicarboxylate symporter. Known pathogenic mutations map to the transport domain.","method":"AlphaFold2 structural modeling; sequence analysis; homology modeling; mapping of known mutations onto structural models","journal":"Bioscience reports","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational prediction only, no experimental validation of transport activity or domain function","pmids":["37431738"],"is_preprint":false},{"year":2025,"finding":"OCA2 functions as a Cl- channel on melanosomes; its loss-of-function reduces melanosomal Cl- and thereby enhances TPC2 (TPCN2) channel activity, lowering melanosomal pH and reducing pigment production. Cytosolic high Cl- inhibits TPC2 while luminal high Cl- enhances TPC2 activity. CRISPR/Cas9 OCA2 KO cell models and OCA2 p.Val443Ile knockin mice with TPCN2 p.Arg210Cys knockin show synergistic hypopigmentation in fur and retina.","method":"Patch-clamp analysis of TPC2 channel activity; CRISPR/Cas9 KO cell models; knockin mouse models; melanin content and pH measurements","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 1 / Strong — patch-clamp electrophysiology establishing Cl- channel activity, CRISPR KO and knockin mouse models with biochemical and phenotypic readouts, multiple orthogonal methods in single rigorous study","pmids":["41443368"],"is_preprint":false},{"year":2019,"finding":"Zebrafish oca2 loss-of-function mutations increase melanocyte sensitivity to cisplatin compared to wild-type, but do not increase cisplatin sensitivity in hair cells of the lateral line, suggesting that Oca2-dependent melanosome maturation contributes to cisplatin resistance specifically in melanocytes, potentially via drug sequestration.","method":"Zebrafish oca2 loss-of-function mutant larvae; cisplatin treatment; quantification of melanocyte and hair cell survival","journal":"Experimental dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with cell-type-specific phenotype, comparison to other melanosome maturation mutants, single lab","pmids":["30977151"],"is_preprint":false},{"year":2014,"finding":"In zebrafish, oca2 loss-of-function results in reduced number of differentiated melanophores (with immature melanosomes) but increased number of differentiated iridophores, indicating cell-type-specific roles for oca2 in chromatophore differentiation. Treatment with bafilomycin A1 (vacuolar ATPase inhibitor/cytoplasmic pH modifier) partially rescues melanosome maturation, consistent with OCA2's role in melanosomal pH regulation.","method":"Positional cloning; zebrafish oca2 mutant characterization; melanoblast and melanophore quantification; transmission electron microscopy; bafilomycin A1 pharmacological rescue","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with cellular phenotype, pharmacological rescue, multiple readouts; single lab","pmids":["24330346"],"is_preprint":false},{"year":2013,"finding":"Two novel OCA2 splicing mutations (IVS14+5G>A and c.2139G>A) were shown by in vitro minigene assay to cause aberrant splicing (exon skipping or altered splice site usage), confirming their causal role in OCA2.","method":"In vitro hybrid-minigene splicing assay; in silico splice site prediction","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro minigene assay directly demonstrating splicing defects, single lab, single method per variant","pmids":["24361966"],"is_preprint":false},{"year":2025,"finding":"OCA2 exon 10 skipping is modulated by both exonic and intronic sequence context. Missense variants in exon 10 significantly influence skipping ratio. The common synonymous variant rs1800404-T (c.1065G>A/p.Ala355=) promotes exon 10 skipping and is associated with lighter skin and hair pigmentation. The exon-10-skipped protein isoform is predicted by structural modeling to exert a dominant-negative effect, explaining a dose-dependent hypopigmentation response.","method":"Minigene functional assay; hybrid human-murine exon/intron combination assays; association analysis in European population; computational structural modeling of skipped-transcript protein","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — minigene splicing assays plus population association, single lab but multiple orthogonal approaches","pmids":["40996958"],"is_preprint":false},{"year":2024,"finding":"Subcellular localization and channel (transporter) activity assays on 30 OCA2 variants of uncertain significance show that pathogenic/likely pathogenic variants exhibit abnormal localization or abnormal channel activity, while benign/likely benign variants show normal function, establishing that OCA2 has measurable channel/transporter activity that is disrupted by disease-causing mutations.","method":"Multiplex assays of variant effect (MAVEs): subcellular localization assay and channel activity assay in cell-based systems; trio whole-exome sequencing for clinical cohort","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assays on multiple variants establishing channel activity as a measurable OCA2 function, validated against ClinVar-classified variants","pmids":["39636647"],"is_preprint":false}],"current_model":"OCA2 encodes a 12-transmembrane melanosomal membrane protein that functions as a Cl- channel/transporter regulating melanosomal ion homeostasis and pH; its loss causes non-acidic melanosomal pH, impairs tyrosinase trafficking and processing, and disrupts melanin synthesis. OCA2 is trafficked from the ER to melanosomes via dileucine-based sorting signals that interact differentially with adaptor complexes AP-1 and AP-3, with BLOC-1 required for delivery to melanosomes regardless of which adaptor is engaged. Its transcription is controlled by a long-range HERC2 intron 86 enhancer that forms an allele-dependent chromatin loop to the OCA2 promoter engaging transcription factors HLTF, LEF1, and MITF, and is also repressed by the transcription factor TBX2. Beyond pigmentation, OCA2 has pleiotropic functions including regulation of sleep and melanosome-dependent chemoresistance."},"narrative":{"mechanistic_narrative":"OCA2 is a melanosomal membrane protein that operates at the first step of melanin synthesis and is directly required for melanin biosynthesis in melanocytes [PMID:8980282, PMID:24282555]. It localizes to the melanosome membrane and regulates melanosomal ion homeostasis and pH: loss of OCA2 yields non-acidic melanosomes, impairs tyrosinase processing, and disrupts pigment production [PMID:11310796, PMID:25656818]. Functionally, OCA2 acts as a Cl- channel whose loss lowers melanosomal Cl-, thereby de-repressing the TPC2 (TPCN2) channel, acidifying the melanosome lumen, and reducing pigmentation; OCA2 and TPCN2 variant knockin mice show synergistic hypopigmentation [PMID:41443368], and variant-effect assays confirm that pathogenic OCA2 mutations disrupt measurable channel/transporter activity [PMID:39636647]. OCA2 traffics from the ER to melanosomes via N-terminal dileucine-based sorting signals recognized differentially by adaptor complexes AP-1 and AP-3, with delivery requiring BLOC-1 in cooperation with either adaptor [PMID:19116314, PMID:22718909, PMID:21392365]. Its transcription is controlled by a long-range HERC2 intron 86 enhancer (rs12913832) that forms an allele-dependent chromatin loop to the OCA2 promoter engaging HLTF, LEF1, and MITF, and is repressed by the transcription factor TBX2 [PMID:18172690, PMID:22234890, PMID:26971330]; common splicing variants such as the synonymous rs1800404 further modulate expression via exon skipping linked to lighter pigmentation [PMID:40996958]. Beyond pigmentation, OCA2 has pleiotropic roles, genetically controlling sleep loss in cavefish [PMID:34293332] and contributing to melanosome-dependent chemoresistance [PMID:30977151].","teleology":[{"year":1997,"claim":"Established that OCA2 is itself required for melanin biosynthesis rather than merely correlated with pigment, resolving whether the gene acts cell-autonomously in melanocytes.","evidence":"Complementation of p-null mouse melanocytes with wild-type and mutant human P cDNA, with melanin content as readout","pmids":["8980282"],"confidence":"High","gaps":["Did not define the molecular activity of OCA2","No localization or mechanism by which it supports melanin synthesis"]},{"year":2001,"claim":"Linked OCA2 to melanosomal physiology by showing it sets melanosomal pH, framing it as an ion-transport regulator at the melanosome membrane.","evidence":"pH measurements in p-deficient vs wild-type mouse melanocytes plus melanosome-membrane localization","pmids":["11310796"],"confidence":"Medium","gaps":["Direct ion-transport activity not demonstrated","Identity of transported anion inferred, not measured"]},{"year":2008,"claim":"Defined where OCA2 must act and how it gets there, showing melanosomal (not ER) localization is required for function and is encoded by a dileucine sorting motif.","evidence":"Live-cell imaging, fractionation, ER-retention rescue, dileucine mutagenesis, and adaptor co-IP in OCA2-deficient melanocytes; plus reporter/EMSA showing HERC2 rs12913832 reduces OCA2 promoter activity allele-specifically","pmids":["19116314","18172690"],"confidence":"High","gaps":["Which adaptors bind each signal not fully resolved in 2008","Identity of allele-specific nuclear factors at rs12913832 unknown"]},{"year":2012,"claim":"Mapped the trafficking and transcriptional machinery for OCA2 — that AP-1/AP-3 read its dileucine signal by sequence context and BLOC-1 is universally required, and that a long-range chromatin loop drives allele-dependent expression.","evidence":"Sorting-signal mutagenesis with epistasis in AP-1/AP-3/BLOC-1 mutant lines and EM; ChIP, 3C, and qRT-PCR in darkly vs lightly pigmented human melanocytes","pmids":["22718909","22234890"],"confidence":"High","gaps":["Structural basis of differential adaptor recognition unresolved","How HLTF/LEF1/MITF cooperate at the enhancer not detailed"]},{"year":2013,"claim":"Placed OCA2 at the first enzymatic step of melanin synthesis and revealed downstream consequences of its loss, including substrate diversion and altered ER-stress signaling.","evidence":"Morpholino knockdown in Astyanax embryos with HPLC metabolite profiling; thapsigargin ER-stress assays in Oca2-null melanocytes with eIF2alpha/UPR readouts; minigene splicing assays for two pathogenic variants","pmids":["24282555","23962237","24361966"],"confidence":"Medium","gaps":["Mechanism linking OCA2 loss to Gadd34-PP1alpha-mediated eIF2alpha dephosphorylation incompletely defined","Substrate diversion to catecholamines not shown to be physiologically significant"]},{"year":2014,"claim":"Cross-species and ultrastructural studies tied OCA2 to melanosome maturation and pH-dependent chromatophore differentiation, while a localization study raised an endosomal/lysosomal alternative.","evidence":"Zebrafish oca2 mutant characterization with EM and bafilomycin rescue; siRNA knockdown with melanosome ultrastructure (2015); antibody-based confocal colocalization with LAMP2/BLOC-1","pmids":["24330346","25656818","25530116"],"confidence":"Medium","gaps":["Localization study (#10) partially conflicts with melanosomal localization reported elsewhere","Cell-type-specific roles in iridophores vs melanophores mechanistically unexplained"]},{"year":2016,"claim":"Identified TBX2 as a direct transcriptional repressor of OCA2, integrating OCA2 expression into hormone-responsive (alpha-MSH/forskolin) melanogenic control.","evidence":"TBX2 siRNA knockdown with double-knockdown epistasis, ChIP, and luciferase reporter assays in mouse melanocytes","pmids":["26971330"],"confidence":"Medium","gaps":["Interplay between TBX2 repression and HERC2 enhancer activation not integrated","Single lab, single model system"]},{"year":2018,"claim":"Demonstrated that OCA2 is the sole genetic determinant of albinism in independently evolved cavefish, establishing strict causal specificity.","evidence":"CRISPR/Cas9 mutagenesis and genetic complementation crosses in Astyanax mexicanus","pmids":["29555241"],"confidence":"High","gaps":["Molecular activity of OCA2 still not directly measured","Does not address pleiotropic roles"]},{"year":2021,"claim":"Revealed OCA2 pleiotropy by genetically separating its role in sleep regulation from pigmentation, broadening its biological function beyond melanin.","evidence":"CRISPR mutagenesis, sleep quantification, non-complementation across cave populations, and QTL co-segregation in Astyanax","pmids":["34293332"],"confidence":"High","gaps":["Mechanism by which OCA2 affects sleep unknown","Whether sleep role depends on melanosomal function untested"]},{"year":2024,"claim":"Established OCA2 channel/transporter activity as a directly measurable function disrupted by disease variants, providing a functional readout for variant classification.","evidence":"Multiplex variant-effect assays of localization and channel activity on 30 VUS, benchmarked against ClinVar classifications; computational structural modeling (2023) predicting an SLC13-like transporter fold and GOLD domain","pmids":["39636647","37431738"],"confidence":"Medium","gaps":["Structural model (#14) is computational with no experimental validation of transport","Substrate identity (Na+/dicarboxylate vs Cl-) not resolved by these studies"]},{"year":2025,"claim":"Defined the direct molecular activity of OCA2 as a melanosomal Cl- channel and the mechanism by which it controls melanosomal pH, via Cl--dependent regulation of the TPC2 channel.","evidence":"Patch-clamp of TPC2, CRISPR/Cas9 OCA2 KO cells, and OCA2/TPCN2 knockin mice with pH and melanin readouts; plus minigene/association analysis of exon-10 skipping and rs1800404","pmids":["41443368","40996958"],"confidence":"High","gaps":["Whether OCA2 transports additional ions or substrates beyond Cl- not excluded","Structural basis of OCA2 Cl- conduction not yet resolved experimentally"]},{"year":null,"claim":"How OCA2's melanosomal Cl- channel function mechanistically connects to its pleiotropic roles in sleep and chemoresistance remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No mechanism linking ion transport to sleep regulation","Drug-sequestration model for chemoresistance not directly tested","No experimental high-resolution structure of OCA2"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,15,20]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0,2,8]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[2,10]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[2,7]}],"pathway":[],"complexes":[],"partners":["TPCN2","AP-3","AP-1","BLOC-1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q04671","full_name":"P protein","aliases":["Melanocyte-specific transporter protein","Pink-eyed dilution protein homolog"],"length_aa":838,"mass_kda":92.8,"function":"Contributes to a melanosome-specific anion (chloride) current that modulates melanosomal pH for optimal tyrosinase activity required for melanogenesis and the melanosome maturation (PubMed:11310796, PubMed:15262401, PubMed:22234890, PubMed:25513726). One of the components of the mammalian pigmentary system (PubMed:15262401, PubMed:18252222, PubMed:7601462). May serve as a key control point at which ethnic skin color variation is determined. Major determinant of brown and/or blue eye color (PubMed:15262401, PubMed:18252222, PubMed:7601462). Seems to regulate the post-translational processing of tyrosinase, which catalyzes the limiting reaction in melanin synthesis (By similarity)","subcellular_location":"Melanosome membrane","url":"https://www.uniprot.org/uniprotkb/Q04671/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/OCA2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/OCA2","total_profiled":1310},"omim":[{"mim_id":"616722","title":"RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CATARACT; RDICC","url":"https://www.omim.org/entry/616722"},{"mim_id":"614559","title":"INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD","url":"https://www.omim.org/entry/614559"},{"mim_id":"613660","title":"CONE-ROD DYSTROPHY 15; CORD15","url":"https://www.omim.org/entry/613660"},{"mim_id":"611409","title":"OCA2 MELANOSOMAL TRANSMEMBRANE PROTEIN; OCA2","url":"https://www.omim.org/entry/611409"},{"mim_id":"610942","title":"MICRO RNA 204; MIR204","url":"https://www.omim.org/entry/610942"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"choroid plexus","ntpm":28.0}],"url":"https://www.proteinatlas.org/search/OCA2"},"hgnc":{"alias_symbol":["BEY","BEY1","BEY2","EYCL","SLC13B1"],"prev_symbol":["D15S12","P","EYCL3","EYCL2"]},"alphafold":{"accession":"Q04671","domains":[{"cath_id":"2.60.120.680","chopping":"206-241_248-260_268-325","consensus_level":"high","plddt":72.6564,"start":206,"end":325},{"cath_id":"-","chopping":"464-538_701-835","consensus_level":"high","plddt":91.1991,"start":464,"end":835},{"cath_id":"1.10.150","chopping":"543-615","consensus_level":"medium","plddt":85.1,"start":543,"end":615}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q04671","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q04671-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q04671-F1-predicted_aligned_error_v6.png","plddt_mean":73.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=OCA2","jax_strain_url":"https://www.jax.org/strain/search?query=OCA2"},"sequence":{"accession":"Q04671","fasta_url":"https://rest.uniprot.org/uniprotkb/Q04671.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q04671/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q04671"}},"corpus_meta":[{"pmid":"18172690","id":"PMC_18172690","title":"Blue eye color in humans may be caused by a perfectly associated founder mutation in a regulatory element located within the HERC2 gene inhibiting OCA2 expression.","date":"2008","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18172690","citation_count":227,"is_preprint":false},{"pmid":"22234890","id":"PMC_22234890","title":"HERC2 rs12913832 modulates human pigmentation by attenuating chromatin-loop formation between a long-range enhancer and the OCA2 promoter.","date":"2012","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/22234890","citation_count":209,"is_preprint":false},{"pmid":"14709592","id":"PMC_14709592","title":"Interactive effects of MC1R and OCA2 on melanoma risk phenotypes.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14709592","citation_count":205,"is_preprint":false},{"pmid":"17236130","id":"PMC_17236130","title":"A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation.","date":"2006","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17236130","citation_count":162,"is_preprint":false},{"pmid":"11310796","id":"PMC_11310796","title":"The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH.","date":"2001","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/11310796","citation_count":139,"is_preprint":false},{"pmid":"8980282","id":"PMC_8980282","title":"Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences.","date":"1997","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/8980282","citation_count":107,"is_preprint":false},{"pmid":"22065085","id":"PMC_22065085","title":"A global view of the OCA2-HERC2 region and pigmentation.","date":"2011","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22065085","citation_count":99,"is_preprint":false},{"pmid":"20221248","id":"PMC_20221248","title":"Association of the OCA2 polymorphism His615Arg with melanin content in east Asian populations: further evidence of convergent evolution of skin pigmentation.","date":"2010","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20221248","citation_count":94,"is_preprint":false},{"pmid":"19208107","id":"PMC_19208107","title":"Interactions between HERC2, OCA2 and MC1R may influence human pigmentation phenotype.","date":"2009","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19208107","citation_count":92,"is_preprint":false},{"pmid":"18650849","id":"PMC_18650849","title":"Analysis of cultured human melanocytes based on polymorphisms within the SLC45A2/MATP, SLC24A5/NCKX5, and OCA2/P loci.","date":"2008","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/18650849","citation_count":91,"is_preprint":false},{"pmid":"29555241","id":"PMC_29555241","title":"CRISPR mutagenesis confirms the role of oca2 in melanin pigmentation in Astyanax mexicanus.","date":"2018","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/29555241","citation_count":82,"is_preprint":false},{"pmid":"24282555","id":"PMC_24282555","title":"A potential benefit of albinism in Astyanax cavefish: downregulation of the oca2 gene increases tyrosine and catecholamine levels as an alternative to melanin synthesis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24282555","citation_count":82,"is_preprint":false},{"pmid":"15889046","id":"PMC_15889046","title":"Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma.","date":"2005","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/15889046","citation_count":74,"is_preprint":false},{"pmid":"19116314","id":"PMC_19116314","title":"Localization to mature melanosomes by virtue of cytoplasmic dileucine motifs is required for human OCA2 function.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19116314","citation_count":64,"is_preprint":false},{"pmid":"12876664","id":"PMC_12876664","title":"MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2).","date":"2003","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12876664","citation_count":62,"is_preprint":false},{"pmid":"22718909","id":"PMC_22718909","title":"Differential recognition of a dileucine-based sorting signal by AP-1 and AP-3 reveals a requirement for both BLOC-1 and AP-3 in delivery of OCA2 to melanosomes.","date":"2012","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/22718909","citation_count":58,"is_preprint":false},{"pmid":"23824587","id":"PMC_23824587","title":"Computational screening of disease-associated mutations in OCA2 gene.","date":"2014","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/23824587","citation_count":57,"is_preprint":false},{"pmid":"20457063","id":"PMC_20457063","title":"Human eye colour and HERC2, OCA2 and MATP.","date":"2010","source":"Forensic science international. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20457063","citation_count":53,"is_preprint":false},{"pmid":"7874125","id":"PMC_7874125","title":"Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2).","date":"1994","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7874125","citation_count":53,"is_preprint":false},{"pmid":"9099845","id":"PMC_9099845","title":"Oculocutaneous albinism (OCA2) in sub-Saharan Africa: distribution of the common 2.7-kb P gene deletion mutation.","date":"1997","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9099845","citation_count":49,"is_preprint":false},{"pmid":"15712365","id":"PMC_15712365","title":"P gene mutations associated with oculocutaneous albinism type II (OCA2).","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15712365","citation_count":45,"is_preprint":false},{"pmid":"34293332","id":"PMC_34293332","title":"Pleiotropic function of the oca2 gene underlies the evolution of sleep loss and albinism in cavefish.","date":"2021","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/34293332","citation_count":44,"is_preprint":false},{"pmid":"7762554","id":"PMC_7762554","title":"Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2).","date":"1995","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7762554","citation_count":44,"is_preprint":false},{"pmid":"20308648","id":"PMC_20308648","title":"Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.","date":"2010","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/20308648","citation_count":43,"is_preprint":false},{"pmid":"17619204","id":"PMC_17619204","title":"Multilocus OCA2 genotypes specify human iris colors.","date":"2007","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17619204","citation_count":43,"is_preprint":false},{"pmid":"21541274","id":"PMC_21541274","title":"Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.","date":"2011","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/21541274","citation_count":42,"is_preprint":false},{"pmid":"8875191","id":"PMC_8875191","title":"Assignment of genes coding for brown eye colour (BEY2) and brown hair colour (HCL3) on chromosome 15q.","date":"1996","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/8875191","citation_count":40,"is_preprint":false},{"pmid":"24330346","id":"PMC_24330346","title":"oca2 Regulation of chromatophore differentiation and number is cell type specific in zebrafish.","date":"2014","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/24330346","citation_count":37,"is_preprint":false},{"pmid":"26597053","id":"PMC_26597053","title":"Amelanism in the corn snake is associated with the insertion of an LTR-retrotransposon in the OCA2 gene.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26597053","citation_count":35,"is_preprint":false},{"pmid":"20629734","id":"PMC_20629734","title":"Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2.","date":"2010","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/20629734","citation_count":34,"is_preprint":false},{"pmid":"23572122","id":"PMC_23572122","title":"Albinism in phylogenetically and geographically distinct populations of Astyanax cavefish arises through the same loss-of-function Oca2 allele.","date":"2013","source":"Heredity","url":"https://pubmed.ncbi.nlm.nih.gov/23572122","citation_count":31,"is_preprint":false},{"pmid":"23601698","id":"PMC_23601698","title":"Gender is a major factor explaining discrepancies in eye colour prediction based on HERC2/OCA2 genotype and the IrisPlex model.","date":"2013","source":"Forensic science international. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23601698","citation_count":30,"is_preprint":false},{"pmid":"25809079","id":"PMC_25809079","title":"Association study confirms the role of two OCA2 polymorphisms in normal skin pigmentation variation in East Asian populations.","date":"2015","source":"American journal of human biology : the official journal of the Human Biology Council","url":"https://pubmed.ncbi.nlm.nih.gov/25809079","citation_count":29,"is_preprint":false},{"pmid":"9341887","id":"PMC_9341887","title":"Type 2 oculocutaneous albinism (OCA2) in Zimbabwe and Cameroon: distribution of the 2.7-kb deletion allele of the P gene.","date":"1997","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9341887","citation_count":29,"is_preprint":false},{"pmid":"18093281","id":"PMC_18093281","title":"Association of polymorphic sites in the OCA2 gene with eye colour using the tree scanning method.","date":"2007","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18093281","citation_count":28,"is_preprint":false},{"pmid":"25410285","id":"PMC_25410285","title":"Interactions between ultraviolet light and MC1R and OCA2 variants are determinants of childhood nevus and freckle phenotypes.","date":"2014","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25410285","citation_count":27,"is_preprint":false},{"pmid":"23103111","id":"PMC_23103111","title":"Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree.","date":"2012","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/23103111","citation_count":27,"is_preprint":false},{"pmid":"24387780","id":"PMC_24387780","title":"Genetic variation in regulatory DNA elements: the case of OCA2 transcriptional regulation.","date":"2014","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/24387780","citation_count":26,"is_preprint":false},{"pmid":"25656818","id":"PMC_25656818","title":"Unrevealing the role of P-protein on melanosome biology and structure, using siRNA-mediated down regulation of OCA2.","date":"2015","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25656818","citation_count":26,"is_preprint":false},{"pmid":"24118800","id":"PMC_24118800","title":"High-resolution array-CGH in patients with oculocutaneous albinism identifies new deletions of the TYR, OCA2, and SLC45A2 genes and a complex rearrangement of the OCA2 gene.","date":"2013","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/24118800","citation_count":26,"is_preprint":false},{"pmid":"17570052","id":"PMC_17570052","title":"Distribution of two Asian-related coding SNPs in the MC1R and OCA2 genes.","date":"2007","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17570052","citation_count":24,"is_preprint":false},{"pmid":"17568986","id":"PMC_17568986","title":"OCA2 481Thr, a hypofunctional allele in pigmentation, is characteristic of northeastern Asian populations.","date":"2007","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17568986","citation_count":24,"is_preprint":false},{"pmid":"7761348","id":"PMC_7761348","title":"The mouse pink-eyed dilution gene: association with hypopigmentation in Prader-Willi and Angelman syndromes and with human OCA2.","date":"1994","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/7761348","citation_count":22,"is_preprint":false},{"pmid":"27468418","id":"PMC_27468418","title":"Importance of nonsynonymous OCA2 variants in human eye color prediction.","date":"2016","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27468418","citation_count":22,"is_preprint":false},{"pmid":"32966289","id":"PMC_32966289","title":"Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32966289","citation_count":20,"is_preprint":false},{"pmid":"11179026","id":"PMC_11179026","title":"In Southern Africa, brown oculocutaneous albinism (BOCA) maps to the OCA2 locus on chromosome 15q: P-gene mutations identified.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11179026","citation_count":20,"is_preprint":false},{"pmid":"21565543","id":"PMC_21565543","title":"Distribution of OCA2∗481Thr and OCA2∗615Arg, associated with hypopigmentation, in several additional populations.","date":"2011","source":"Legal medicine (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/21565543","citation_count":19,"is_preprint":false},{"pmid":"18528436","id":"PMC_18528436","title":"Linkage and association analysis of spectrophotometrically quantified hair color in Australian adolescents: the effect of OCA2 and HERC2.","date":"2008","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/18528436","citation_count":18,"is_preprint":false},{"pmid":"21392365","id":"PMC_21392365","title":"Functional interactions between OCA2 and the protein complexes BLOC-1, BLOC-2, and AP-3 inferred from epistatic analyses of mouse coat pigmentation.","date":"2010","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/21392365","citation_count":16,"is_preprint":false},{"pmid":"35601449","id":"PMC_35601449","title":"Oca2 targeting using CRISPR/Cas9 in the Malawi cichlid Astatotilapia calliptera.","date":"2022","source":"Royal Society open science","url":"https://pubmed.ncbi.nlm.nih.gov/35601449","citation_count":15,"is_preprint":false},{"pmid":"28973042","id":"PMC_28973042","title":"OCA2 splice site variant in German Spitz dogs with oculocutaneous albinism.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28973042","citation_count":15,"is_preprint":false},{"pmid":"25919014","id":"PMC_25919014","title":"Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25919014","citation_count":15,"is_preprint":false},{"pmid":"17767372","id":"PMC_17767372","title":"Oculocutaneous albinism type 2 (OCA2) with homozygous 2.7-kb deletion of the P gene and sickle cell disease in a Cameroonian family. Identification of a common TAG haplotype in the mutated P gene.","date":"2007","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17767372","citation_count":15,"is_preprint":false},{"pmid":"24361966","id":"PMC_24361966","title":"Functional characterization of two novel splicing mutations in the OCA2 gene associated with oculocutaneous albinism type II.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24361966","citation_count":15,"is_preprint":false},{"pmid":"31131985","id":"PMC_31131985","title":"Genome of the Malawi golden cichlid fish (Melanochromis auratus) reveals exon loss of oca2 in an amelanistic morph.","date":"2019","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/31131985","citation_count":15,"is_preprint":false},{"pmid":"32963319","id":"PMC_32963319","title":"The distinctive geographic patterns of common pigmentation variants at the OCA2 gene.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32963319","citation_count":14,"is_preprint":false},{"pmid":"21085994","id":"PMC_21085994","title":"High resolution mapping of OCA2 intragenic rearrangements and identification of a founder effect associated with a deletion in Polish albino patients.","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21085994","citation_count":14,"is_preprint":false},{"pmid":"10671067","id":"PMC_10671067","title":"Mutations of the human P gene associated with Type II oculocutaneous albinism (OCA2). Mutations in brief no. 205. Online.","date":"1998","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/10671067","citation_count":14,"is_preprint":false},{"pmid":"32259106","id":"PMC_32259106","title":"Nonhuman Primate Model of Oculocutaneous Albinism with TYR and OCA2 Mutations.","date":"2020","source":"Research (Washington, D.C.)","url":"https://pubmed.ncbi.nlm.nih.gov/32259106","citation_count":13,"is_preprint":false},{"pmid":"23962237","id":"PMC_23962237","title":"Loss of Oca2 disrupts the unfolded protein response and increases resistance to endoplasmic reticulum stress in melanocytes.","date":"2013","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/23962237","citation_count":13,"is_preprint":false},{"pmid":"19472299","id":"PMC_19472299","title":"Genotyping of five single nucleotide polymorphisms in the OCA2 and HERC2 genes associated with blue-brown eye color in the Japanese population.","date":"2009","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/19472299","citation_count":13,"is_preprint":false},{"pmid":"12727022","id":"PMC_12727022","title":"A novel P gene missense mutation in a Japanese patient with oculocutaneous albinism type II (OCA2).","date":"2003","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/12727022","citation_count":12,"is_preprint":false},{"pmid":"20019752","id":"PMC_20019752","title":"Inheritance of a novel mutated allele of the OCA2 gene associated with high incidence of oculocutaneous albinism in a Polynesian community.","date":"2009","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20019752","citation_count":12,"is_preprint":false},{"pmid":"16369963","id":"PMC_16369963","title":"Albinism (OCA2) in Amerindians.","date":"2005","source":"American journal of physical anthropology","url":"https://pubmed.ncbi.nlm.nih.gov/16369963","citation_count":11,"is_preprint":false},{"pmid":"37431738","id":"PMC_37431738","title":"Structural insights into pink-eyed dilution protein (Oca2).","date":"2023","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/37431738","citation_count":10,"is_preprint":false},{"pmid":"31199599","id":"PMC_31199599","title":"Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31199599","citation_count":10,"is_preprint":false},{"pmid":"28456133","id":"PMC_28456133","title":"Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs.","date":"2017","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28456133","citation_count":10,"is_preprint":false},{"pmid":"34246199","id":"PMC_34246199","title":"A custom capture sequence approach for oculocutaneous albinism identifies structural variant alleles at the OCA2 locus.","date":"2021","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/34246199","citation_count":10,"is_preprint":false},{"pmid":"34155719","id":"PMC_34155719","title":"Identification of OCA2 as a novel locus for the co-morbidity of asthma-plus-eczema.","date":"2021","source":"Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34155719","citation_count":9,"is_preprint":false},{"pmid":"26971330","id":"PMC_26971330","title":"The transcription factor TBX2 regulates melanogenesis in melanocytes by repressing Oca2.","date":"2016","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26971330","citation_count":8,"is_preprint":false},{"pmid":"40094260","id":"PMC_40094260","title":"Mutations in the albinism gene oca2 alter vision-dependent prey capture behavior in the Mexican tetra.","date":"2025","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/40094260","citation_count":8,"is_preprint":false},{"pmid":"16573532","id":"PMC_16573532","title":"Characterization of OCA2 cDNA in different porcine breeds and analysis of its potential effect on skin pigmentation in a red Iberian strain.","date":"2006","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16573532","citation_count":8,"is_preprint":false},{"pmid":"21621018","id":"PMC_21621018","title":"Hexasomy of the Prader-Willi/Angelman critical region, including the OCA2 gene, in a patient with pigmentary dysplasia: case report.","date":"2011","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21621018","citation_count":8,"is_preprint":false},{"pmid":"39349469","id":"PMC_39349469","title":"The co-occurrence of genetic variants in the TYR and OCA2 genes confers susceptibility to albinism.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39349469","citation_count":7,"is_preprint":false},{"pmid":"37650133","id":"PMC_37650133","title":"Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism.","date":"2023","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/37650133","citation_count":7,"is_preprint":false},{"pmid":"20404084","id":"PMC_20404084","title":"Transcriptional activation of the general amino acid permease gene per1 by the histone deacetylase Clr6 Is regulated by Oca2 kinase.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20404084","citation_count":7,"is_preprint":false},{"pmid":"25736709","id":"PMC_25736709","title":"A nonsense nucleotide substitution in the oculocutaneous albinism II gene underlies the original pink-eyed dilution allele (Oca2(p)) in mice.","date":"2015","source":"Experimental animals","url":"https://pubmed.ncbi.nlm.nih.gov/25736709","citation_count":7,"is_preprint":false},{"pmid":"25937426","id":"PMC_25937426","title":"Commentary on: \"Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study.\" Tombal B, Borre M, Rathenborg P, Werbrouck P, Van Poppel H, Heidenreich A, Iversen P, Braeckman J, Heracek J, Baskin-Bey E, Ouatas T, Perabo F, Phung D, Hirmand M, Smith MR. Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. Electronic address: bertrand.tombal@uclouvain.be. Aarhus University Hospital, Aarhus, Denmark. Herlev Hospital, Herlev, Denmark. AZ Groeninge Kortrijk, Kortrijk, Belgium. UZ Leuven, Leuven, Belgium. Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. UZ Brussel, Brussels, Belgium. Univerzita Karlova v Praze, Prague, Czech Republic. Astellas Pharma Global Development, Leiden, Netherlands. Astellas Pharma Global Development, Northbrook, IL, USA. Medivation Inc, San Francisco, CA, USA. Massachusetts General Hospital Cancer Center, Boston, MA, USA: Lancet Oncol. 2014 May;15(6):592-600; doi: 10.1016/S1470-2045(14)70129-9. [Epub 2014 Apr 14].","date":"2015","source":"Urologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25937426","citation_count":7,"is_preprint":false},{"pmid":"29409738","id":"PMC_29409738","title":"OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29409738","citation_count":6,"is_preprint":false},{"pmid":"30977151","id":"PMC_30977151","title":"Melanosome maturation proteins Oca2, Mitfa and Vps11 are differentially required for cisplatin resistance in zebrafish melanocytes.","date":"2019","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/30977151","citation_count":6,"is_preprint":false},{"pmid":"31345173","id":"PMC_31345173","title":"Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report.","date":"2019","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31345173","citation_count":6,"is_preprint":false},{"pmid":"35328057","id":"PMC_35328057","title":"Delineating Novel and Known Pathogenic Variants in TYR, OCA2 and HPS-1 Genes in Eight Oculocutaneous Albinism (OCA) Pakistani Families.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35328057","citation_count":5,"is_preprint":false},{"pmid":"36980970","id":"PMC_36980970","title":"Association between Variants in the OCA2-HERC2 Region and Blue Eye Colour in HERC2 rs12913832 AA and AG Individuals.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36980970","citation_count":5,"is_preprint":false},{"pmid":"25530116","id":"PMC_25530116","title":"Oculocutaneous albinism: developing novel antibodies targeting the proteins associated with OCA2 and OCA4.","date":"2014","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/25530116","citation_count":5,"is_preprint":false},{"pmid":"39636647","id":"PMC_39636647","title":"Curation of OCA2 Variants of Uncertain Significance From Chinese Oculocutaneous Albinism Patients Based on Multiplex Assays.","date":"2024","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/39636647","citation_count":5,"is_preprint":false},{"pmid":"23063908","id":"PMC_23063908","title":"Albinism and disease causing pathogens in Tanzania: are alleles that are associated with OCA2 being maintained by balancing selection?","date":"2012","source":"Medical hypotheses","url":"https://pubmed.ncbi.nlm.nih.gov/23063908","citation_count":5,"is_preprint":false},{"pmid":"28451379","id":"PMC_28451379","title":"Retrospective analysis in oculocutaneous albinism patients for the 2.7 kb deletion in the OCA2 gene revealed a co-segregation of the controversial variant, p.R305W.","date":"2017","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/28451379","citation_count":5,"is_preprint":false},{"pmid":"37234755","id":"PMC_37234755","title":"Identification of Polymorphisms in the HERC2-OCA2 Gene Locus and their Association with Feather Color in Quail.","date":"2023","source":"The journal of poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/37234755","citation_count":4,"is_preprint":false},{"pmid":"38317267","id":"PMC_38317267","title":"Genetic analysis of albinism caused by compound heterozygous mutations of the OCA2 gene in a Chinese family.","date":"2024","source":"Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/38317267","citation_count":4,"is_preprint":false},{"pmid":"32741191","id":"PMC_32741191","title":"A new type of oculocutaneous albinism with a novel OCA2 mutation.","date":"2020","source":"Yeungnam University journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32741191","citation_count":4,"is_preprint":false},{"pmid":"37234286","id":"PMC_37234286","title":"Redescription of Periplanetaarabica (Bey-Bienko, 1938) (Blattodea, Blattidae), with a comparative analysis of three species of Periplaneta Burmeister, 1838 (sensu stricto).","date":"2023","source":"ZooKeys","url":"https://pubmed.ncbi.nlm.nih.gov/37234286","citation_count":4,"is_preprint":false},{"pmid":"37956964","id":"PMC_37956964","title":"Unveiling genetics of non-syndromic albinism using whole exome sequencing: A comprehensive study of TYR, TYRP1, OCA2 and MC1R genes in 17 families.","date":"2023","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/37956964","citation_count":4,"is_preprint":false},{"pmid":"39456217","id":"PMC_39456217","title":"Modulating OCA2 Expression as a Promising Approach to Enhance Skin Brightness and Reduce Dark Spots.","date":"2024","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39456217","citation_count":3,"is_preprint":false},{"pmid":"36374481","id":"PMC_36374481","title":"Resistance to Beta-cypermethrin, Azadirachtin, and Matrine, and Biochemical Characterization of Field Populations of Oedaleus asiaticus (Bey-Bienko) in Inner Mongolia, Northern China.","date":"2022","source":"Journal of insect science (Online)","url":"https://pubmed.ncbi.nlm.nih.gov/36374481","citation_count":3,"is_preprint":false},{"pmid":"31216817","id":"PMC_31216817","title":"[Correlation between single nucleotide polymorphisms of rs4778137 located in OCA2 gene and clinical response of breast cancer patients receiving neoadjuvant chemotherapy].","date":"2019","source":"Zhonghua yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/31216817","citation_count":2,"is_preprint":false},{"pmid":"41443368","id":"PMC_41443368","title":"OCA2 deficiency enhances TPC2 channel activity to reduce melanosomal pH and pigment production.","date":"2025","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/41443368","citation_count":1,"is_preprint":false},{"pmid":"38926510","id":"PMC_38926510","title":"Functional analysis of two mutation sites in the OCA2 gene.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38926510","citation_count":1,"is_preprint":false},{"pmid":"39556609","id":"PMC_39556609","title":"Ancestral origins of TYR and OCA2 gene mutations in oculocutaneous albinism from two admixed populations in Colombia.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/39556609","citation_count":1,"is_preprint":false},{"pmid":"40996958","id":"PMC_40996958","title":"From paleness to albinism: Contribution of OCA2 exon 10 skipping to hypopigmentation.","date":"2025","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40996958","citation_count":1,"is_preprint":false},{"pmid":"37471664","id":"PMC_37471664","title":"Mutational Analysis of TYR, OCA2, SLC45A2, and TYRP1 Genes Identifies Novel and Reported Mutations in Chinese Families with Oculocutaneous Albinism.","date":"2023","source":"Alternative therapies in health and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37471664","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49490,"output_tokens":5633,"usd":0.116483,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14192,"output_tokens":3840,"usd":0.08348,"stage2_stop_reason":"end_turn"},"total_usd":0.199963,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"The OCA2/P protein localizes to the melanosome membrane and is required for normal melanosomal pH; melanosomes from p-deficient mouse melanocytes have non-acidic (rather than normal acidic) pH, suggesting OCA2 regulates melanosomal pH in conjunction with the ATP-driven proton pump, likely by transporting anions to compensate for proton charge.\",\n      \"method\": \"pH measurements in cultured melanocytes from p-deficient vs wild-type mice; subcellular fractionation and localization to melanosome membrane\",\n      \"journal\": \"Pigment cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct pH measurement in Oca2-null vs WT melanocytes, localization to melanosome membrane, single lab but multiple orthogonal observations\",\n      \"pmids\": [\"11310796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Normal human P/OCA2 cDNA complements hypopigmentation in p-null mouse melanocytes, restoring melanin biosynthesis; OCA2 missense mutations (A481T, V443I) show minimal or partial complementation, establishing that OCA2 is directly required for melanin biosynthesis in melanocytes.\",\n      \"method\": \"Transfection of p-null melanocytes with wild-type and mutant human P cDNA; melanin content assay as functional readout\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution/complementation assay with mutagenesis, directly establishes OCA2 function and allele pathogenicity\",\n      \"pmids\": [\"8980282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Endogenous OCA2 rapidly exits the ER and localizes to melanosomes in melanocytic cells (and to lysosomes in non-pigment cells). Melanosomal localization — not ER retention — is required for OCA2 function in melanin synthesis. A conserved N-terminal acidic dileucine motif is required for steady-state melanosomal localization; a second dileucine signal confers lysosomal localization. The two dileucine signals interact differentially with cytoplasmic adaptor proteins involved in melanosome trafficking.\",\n      \"method\": \"Live-cell imaging, subcellular fractionation, ER-retention mutagenesis rescue assays in OCA2-deficient melanocytes, mutagenesis of dileucine motifs, co-immunoprecipitation with adaptor proteins\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (localization, functional rescue with mutants, mutagenesis, adaptor binding), rigorous controls establishing subcellular localization tied to function\",\n      \"pmids\": [\"19116314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Delivery of OCA2 to melanosomes requires both AP-3 and BLOC-1. AP-1 and AP-3 recognize the dileucine-based sorting signal of OCA2 based on primary sequence context, not position. AP-3 binding is necessary for steady-state melanosomal localization. Unlike tyrosinase (which uses AP-3 alone), both AP-1- and AP-3-favoring OCA2 variants require BLOC-1 for melanosomal transport, indicating BLOC-1 can cooperate with either adaptor during cargo sorting.\",\n      \"method\": \"Targeted mutagenesis of OCA2 dileucine sorting signal; functional complementation assays in OCA2-deficient cells; epistasis with AP-1, AP-3, BLOC-1 mutant cell lines; electron microscopy\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — mutagenesis combined with functional rescue, epistasis experiments with multiple adaptor-deficient lines, multiple orthogonal readouts\",\n      \"pmids\": [\"22718909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Genetic epistasis experiments in mice show that BLOC-1 (pallid allele) is epistatic to OCA2 (pink-eyed dilution), and OCA2 deficiency acts as a semi-dominant enhancer of BLOC-2 (cocoa) and AP-3 (pearl) mutant phenotypes, establishing functional links between OCA2 and these three protein complexes in melanosome biogenesis.\",\n      \"method\": \"Double-mutant coat color epistasis analysis in C57BL/6J mice using pink-eyed dilution (Oca2), pallid (BLOC-1), cocoa (BLOC-2), and pearl (AP-3) alleles\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in vivo, single lab, well-controlled double-mutant phenotypes\",\n      \"pmids\": [\"21392365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The HERC2 intron 86 SNP rs12913832 region acts as a regulatory element that significantly reduces OCA2 promoter activity; the two alleles bind different subsets of nuclear extracts, providing a cis-regulatory mechanism for allele-specific OCA2 expression.\",\n      \"method\": \"Luciferase reporter assay in cell cultures; electrophoretic mobility shift assay (EMSA)\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal in vitro methods (reporter assay + EMSA), single lab\",\n      \"pmids\": [\"18172690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The HERC2 rs12913832 region functions as a long-range enhancer regulating OCA2 transcription. In darkly pigmented melanocytes (T allele), transcription factors HLTF, LEF1, and MITF bind this enhancer and a chromatin loop forms between the enhancer and the OCA2 promoter, leading to elevated OCA2 expression. In lightly pigmented melanocytes (C allele), chromatin-loop formation, TF recruitment, and OCA2 expression are all reduced.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for TF binding; chromosome conformation capture (3C) for chromatin looping; quantitative RT-PCR for OCA2 expression in darkly vs lightly pigmented human melanocytes\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (ChIP, 3C, qRT-PCR) in primary human melanocytes, directly linking SNP allele to TF binding, chromatin looping and gene expression\",\n      \"pmids\": [\"22234890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Loss of Oca2 in melanocytes leads to accumulation of tyrosinase in the ER, arrest of the unfolded protein response (UPR), and increased resistance to ER stress. In Oca2-null melanocytes, thapsigargin-induced ER stress triggers rapid eIF2α dephosphorylation (rather than phosphorylation) mediated by the Gadd34-PP1α phosphatase complex, suppressing pro-apoptotic PERK signaling and promoting cell survival.\",\n      \"method\": \"Thapsigargin treatment of Oca2-null vs wild-type melanocytes; immunoblotting for eIF2α phosphorylation, UPR markers; pharmacological inhibition of Gadd34-PP1α complex; cell viability assays\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined molecular phenotype, pharmacological rescue, multiple readouts; single lab\",\n      \"pmids\": [\"23962237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"siRNA-mediated knockdown of OCA2/P-protein in melan-a melanocytes significantly alters melanosomal morphology (size, shape, type, number) and reduces melanin content and tyrosinase-related protein levels, directly demonstrating OCA2's role in melanosome biogenesis.\",\n      \"method\": \"siRNA transfection of melan-a melanocytes, B16F10 and melan-p1 cells; transmission electron microscopy of melanosomes; melanin content and tyrosinase activity assays\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — siRNA KD with defined ultrastructural and biochemical phenotype, multiple cell lines, single lab\",\n      \"pmids\": [\"25656818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TBX2 transcription factor represses OCA2 expression in melanocytes. α-MSH and forskolin reduce TBX2 expression while stimulating melanogenesis. TBX2 knockdown increases OCA2 expression and melanin production; combined knockdown of TBX2 and OCA2 blocks this effect. ChIP and reporter assays show TBX2 directly binds and represses the OCA2 promoter.\",\n      \"method\": \"siRNA knockdown of TBX2 in primary and immortalized mouse melanocytes; chromatin immunoprecipitation (ChIP); luciferase reporter assay; melanin content measurement\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP + reporter assay + genetic epistasis (double KD), single lab, two orthogonal methods\",\n      \"pmids\": [\"26971330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"OCA2 colocalized with LAMP2 (a lysosomal/late endosomal marker) and significantly with BLOC-1, but not with ER, Golgi, or melanosome markers, when examined with newly generated specific antibodies in human melanocytes and RPE cells.\",\n      \"method\": \"Immunohistochemistry and confocal microscopy with newly generated anti-P antibodies; co-localization with subcellular organelle markers\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single localization method, no functional consequence linked; partially contradicts other papers that show melanosomal localization\",\n      \"pmids\": [\"25530116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CRISPR/Cas9-generated oca2 loss-of-function mutations in surface Astyanax mexicanus produce albinism due to disruption of the first step in melanin synthesis. Hybrid offspring from crosses of oca2-mutant surface fish with albino cavefish are albino, demonstrating that oca2 is solely responsible for albinism in multiple independently evolved cavefish populations.\",\n      \"method\": \"CRISPR/Cas9 mutagenesis in Astyanax mexicanus; genetic complementation test (cross between engineered surface mutants and cavefish)\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — CRISPR KO plus genetic complementation in vivo, directly establishes causal and exclusive role of oca2 in albinism\",\n      \"pmids\": [\"29555241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Downregulation of oca2 expression in Astyanax surface fish embryos delays development of pigmented melanophores and simultaneously increases L-tyrosine and dopamine levels, demonstrating that OCA2 operates at the first step of the melanin synthesis pathway and that its loss diverts substrate (L-tyrosine) to catecholamine synthesis.\",\n      \"method\": \"Morpholino knockdown of oca2 in Astyanax surface fish embryos; HPLC measurement of L-tyrosine, dopamine, and norepinephrine; melanophore counting\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — morpholino KD with biochemical (HPLC) and cellular (melanophore) readouts in vivo, single lab\",\n      \"pmids\": [\"24282555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"oca2 has a pleiotropic role regulating both pigmentation and sleep. Surface Astyanax fish with engineered oca2 mutations show both albinism and reduced sleep. The oca2 mutation fails to complement sleep loss when oca2-mutant surface fish are crossed to independently evolved albino cavefish, establishing that oca2 is genetically responsible for sleep loss as well as albinism in cavefish.\",\n      \"method\": \"CRISPR/Cas9 oca2 mutagenesis; sleep quantification in F2 hybrid fish and oca2 surface mutants; genetic non-complementation test across cave populations; QTL co-segregation analysis\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — CRISPR KO combined with non-complementation genetics and QTL analysis, multiple independent approaches in same study\",\n      \"pmids\": [\"34293332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Computational structural modeling (AlphaFold2) suggests OCA2 adopts a transporter fold similar to SLC13 family members (scaffold and transport domains with pseudo-inverted repeat topology including re-entrant loops), an elevator-type transport mechanism, and contains a cryptic GOLD domain likely responsible for ER-to-Golgi trafficking. Conserved asparagine residues in the putative ligand-binding site suggest OCA2 may function as a Na+/dicarboxylate symporter. Known pathogenic mutations map to the transport domain.\",\n      \"method\": \"AlphaFold2 structural modeling; sequence analysis; homology modeling; mapping of known mutations onto structural models\",\n      \"journal\": \"Bioscience reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational prediction only, no experimental validation of transport activity or domain function\",\n      \"pmids\": [\"37431738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"OCA2 functions as a Cl- channel on melanosomes; its loss-of-function reduces melanosomal Cl- and thereby enhances TPC2 (TPCN2) channel activity, lowering melanosomal pH and reducing pigment production. Cytosolic high Cl- inhibits TPC2 while luminal high Cl- enhances TPC2 activity. CRISPR/Cas9 OCA2 KO cell models and OCA2 p.Val443Ile knockin mice with TPCN2 p.Arg210Cys knockin show synergistic hypopigmentation in fur and retina.\",\n      \"method\": \"Patch-clamp analysis of TPC2 channel activity; CRISPR/Cas9 KO cell models; knockin mouse models; melanin content and pH measurements\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — patch-clamp electrophysiology establishing Cl- channel activity, CRISPR KO and knockin mouse models with biochemical and phenotypic readouts, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"41443368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Zebrafish oca2 loss-of-function mutations increase melanocyte sensitivity to cisplatin compared to wild-type, but do not increase cisplatin sensitivity in hair cells of the lateral line, suggesting that Oca2-dependent melanosome maturation contributes to cisplatin resistance specifically in melanocytes, potentially via drug sequestration.\",\n      \"method\": \"Zebrafish oca2 loss-of-function mutant larvae; cisplatin treatment; quantification of melanocyte and hair cell survival\",\n      \"journal\": \"Experimental dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with cell-type-specific phenotype, comparison to other melanosome maturation mutants, single lab\",\n      \"pmids\": [\"30977151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In zebrafish, oca2 loss-of-function results in reduced number of differentiated melanophores (with immature melanosomes) but increased number of differentiated iridophores, indicating cell-type-specific roles for oca2 in chromatophore differentiation. Treatment with bafilomycin A1 (vacuolar ATPase inhibitor/cytoplasmic pH modifier) partially rescues melanosome maturation, consistent with OCA2's role in melanosomal pH regulation.\",\n      \"method\": \"Positional cloning; zebrafish oca2 mutant characterization; melanoblast and melanophore quantification; transmission electron microscopy; bafilomycin A1 pharmacological rescue\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with cellular phenotype, pharmacological rescue, multiple readouts; single lab\",\n      \"pmids\": [\"24330346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Two novel OCA2 splicing mutations (IVS14+5G>A and c.2139G>A) were shown by in vitro minigene assay to cause aberrant splicing (exon skipping or altered splice site usage), confirming their causal role in OCA2.\",\n      \"method\": \"In vitro hybrid-minigene splicing assay; in silico splice site prediction\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro minigene assay directly demonstrating splicing defects, single lab, single method per variant\",\n      \"pmids\": [\"24361966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"OCA2 exon 10 skipping is modulated by both exonic and intronic sequence context. Missense variants in exon 10 significantly influence skipping ratio. The common synonymous variant rs1800404-T (c.1065G>A/p.Ala355=) promotes exon 10 skipping and is associated with lighter skin and hair pigmentation. The exon-10-skipped protein isoform is predicted by structural modeling to exert a dominant-negative effect, explaining a dose-dependent hypopigmentation response.\",\n      \"method\": \"Minigene functional assay; hybrid human-murine exon/intron combination assays; association analysis in European population; computational structural modeling of skipped-transcript protein\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — minigene splicing assays plus population association, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"40996958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Subcellular localization and channel (transporter) activity assays on 30 OCA2 variants of uncertain significance show that pathogenic/likely pathogenic variants exhibit abnormal localization or abnormal channel activity, while benign/likely benign variants show normal function, establishing that OCA2 has measurable channel/transporter activity that is disrupted by disease-causing mutations.\",\n      \"method\": \"Multiplex assays of variant effect (MAVEs): subcellular localization assay and channel activity assay in cell-based systems; trio whole-exome sequencing for clinical cohort\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assays on multiple variants establishing channel activity as a measurable OCA2 function, validated against ClinVar-classified variants\",\n      \"pmids\": [\"39636647\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"OCA2 encodes a 12-transmembrane melanosomal membrane protein that functions as a Cl- channel/transporter regulating melanosomal ion homeostasis and pH; its loss causes non-acidic melanosomal pH, impairs tyrosinase trafficking and processing, and disrupts melanin synthesis. OCA2 is trafficked from the ER to melanosomes via dileucine-based sorting signals that interact differentially with adaptor complexes AP-1 and AP-3, with BLOC-1 required for delivery to melanosomes regardless of which adaptor is engaged. Its transcription is controlled by a long-range HERC2 intron 86 enhancer that forms an allele-dependent chromatin loop to the OCA2 promoter engaging transcription factors HLTF, LEF1, and MITF, and is also repressed by the transcription factor TBX2. Beyond pigmentation, OCA2 has pleiotropic functions including regulation of sleep and melanosome-dependent chemoresistance.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"OCA2 is a melanosomal membrane protein that operates at the first step of melanin synthesis and is directly required for melanin biosynthesis in melanocytes [#1, #12]. It localizes to the melanosome membrane and regulates melanosomal ion homeostasis and pH: loss of OCA2 yields non-acidic melanosomes, impairs tyrosinase processing, and disrupts pigment production [#0, #8]. Functionally, OCA2 acts as a Cl- channel whose loss lowers melanosomal Cl-, thereby de-repressing the TPC2 (TPCN2) channel, acidifying the melanosome lumen, and reducing pigmentation; OCA2 and TPCN2 variant knockin mice show synergistic hypopigmentation [#15], and variant-effect assays confirm that pathogenic OCA2 mutations disrupt measurable channel/transporter activity [#20]. OCA2 traffics from the ER to melanosomes via N-terminal dileucine-based sorting signals recognized differentially by adaptor complexes AP-1 and AP-3, with delivery requiring BLOC-1 in cooperation with either adaptor [#2, #3, #4]. Its transcription is controlled by a long-range HERC2 intron 86 enhancer (rs12913832) that forms an allele-dependent chromatin loop to the OCA2 promoter engaging HLTF, LEF1, and MITF, and is repressed by the transcription factor TBX2 [#5, #6, #9]; common splicing variants such as the synonymous rs1800404 further modulate expression via exon skipping linked to lighter pigmentation [#19]. Beyond pigmentation, OCA2 has pleiotropic roles, genetically controlling sleep loss in cavefish [#13] and contributing to melanosome-dependent chemoresistance [#16].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established that OCA2 is itself required for melanin biosynthesis rather than merely correlated with pigment, resolving whether the gene acts cell-autonomously in melanocytes.\",\n      \"evidence\": \"Complementation of p-null mouse melanocytes with wild-type and mutant human P cDNA, with melanin content as readout\",\n      \"pmids\": [\"8980282\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular activity of OCA2\", \"No localization or mechanism by which it supports melanin synthesis\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Linked OCA2 to melanosomal physiology by showing it sets melanosomal pH, framing it as an ion-transport regulator at the melanosome membrane.\",\n      \"evidence\": \"pH measurements in p-deficient vs wild-type mouse melanocytes plus melanosome-membrane localization\",\n      \"pmids\": [\"11310796\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ion-transport activity not demonstrated\", \"Identity of transported anion inferred, not measured\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined where OCA2 must act and how it gets there, showing melanosomal (not ER) localization is required for function and is encoded by a dileucine sorting motif.\",\n      \"evidence\": \"Live-cell imaging, fractionation, ER-retention rescue, dileucine mutagenesis, and adaptor co-IP in OCA2-deficient melanocytes; plus reporter/EMSA showing HERC2 rs12913832 reduces OCA2 promoter activity allele-specifically\",\n      \"pmids\": [\"19116314\", \"18172690\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which adaptors bind each signal not fully resolved in 2008\", \"Identity of allele-specific nuclear factors at rs12913832 unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapped the trafficking and transcriptional machinery for OCA2 — that AP-1/AP-3 read its dileucine signal by sequence context and BLOC-1 is universally required, and that a long-range chromatin loop drives allele-dependent expression.\",\n      \"evidence\": \"Sorting-signal mutagenesis with epistasis in AP-1/AP-3/BLOC-1 mutant lines and EM; ChIP, 3C, and qRT-PCR in darkly vs lightly pigmented human melanocytes\",\n      \"pmids\": [\"22718909\", \"22234890\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of differential adaptor recognition unresolved\", \"How HLTF/LEF1/MITF cooperate at the enhancer not detailed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placed OCA2 at the first enzymatic step of melanin synthesis and revealed downstream consequences of its loss, including substrate diversion and altered ER-stress signaling.\",\n      \"evidence\": \"Morpholino knockdown in Astyanax embryos with HPLC metabolite profiling; thapsigargin ER-stress assays in Oca2-null melanocytes with eIF2alpha/UPR readouts; minigene splicing assays for two pathogenic variants\",\n      \"pmids\": [\"24282555\", \"23962237\", \"24361966\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking OCA2 loss to Gadd34-PP1alpha-mediated eIF2alpha dephosphorylation incompletely defined\", \"Substrate diversion to catecholamines not shown to be physiologically significant\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Cross-species and ultrastructural studies tied OCA2 to melanosome maturation and pH-dependent chromatophore differentiation, while a localization study raised an endosomal/lysosomal alternative.\",\n      \"evidence\": \"Zebrafish oca2 mutant characterization with EM and bafilomycin rescue; siRNA knockdown with melanosome ultrastructure (2015); antibody-based confocal colocalization with LAMP2/BLOC-1\",\n      \"pmids\": [\"24330346\", \"25656818\", \"25530116\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Localization study (#10) partially conflicts with melanosomal localization reported elsewhere\", \"Cell-type-specific roles in iridophores vs melanophores mechanistically unexplained\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified TBX2 as a direct transcriptional repressor of OCA2, integrating OCA2 expression into hormone-responsive (alpha-MSH/forskolin) melanogenic control.\",\n      \"evidence\": \"TBX2 siRNA knockdown with double-knockdown epistasis, ChIP, and luciferase reporter assays in mouse melanocytes\",\n      \"pmids\": [\"26971330\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interplay between TBX2 repression and HERC2 enhancer activation not integrated\", \"Single lab, single model system\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated that OCA2 is the sole genetic determinant of albinism in independently evolved cavefish, establishing strict causal specificity.\",\n      \"evidence\": \"CRISPR/Cas9 mutagenesis and genetic complementation crosses in Astyanax mexicanus\",\n      \"pmids\": [\"29555241\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular activity of OCA2 still not directly measured\", \"Does not address pleiotropic roles\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed OCA2 pleiotropy by genetically separating its role in sleep regulation from pigmentation, broadening its biological function beyond melanin.\",\n      \"evidence\": \"CRISPR mutagenesis, sleep quantification, non-complementation across cave populations, and QTL co-segregation in Astyanax\",\n      \"pmids\": [\"34293332\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which OCA2 affects sleep unknown\", \"Whether sleep role depends on melanosomal function untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established OCA2 channel/transporter activity as a directly measurable function disrupted by disease variants, providing a functional readout for variant classification.\",\n      \"evidence\": \"Multiplex variant-effect assays of localization and channel activity on 30 VUS, benchmarked against ClinVar classifications; computational structural modeling (2023) predicting an SLC13-like transporter fold and GOLD domain\",\n      \"pmids\": [\"39636647\", \"37431738\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural model (#14) is computational with no experimental validation of transport\", \"Substrate identity (Na+/dicarboxylate vs Cl-) not resolved by these studies\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined the direct molecular activity of OCA2 as a melanosomal Cl- channel and the mechanism by which it controls melanosomal pH, via Cl--dependent regulation of the TPC2 channel.\",\n      \"evidence\": \"Patch-clamp of TPC2, CRISPR/Cas9 OCA2 KO cells, and OCA2/TPCN2 knockin mice with pH and melanin readouts; plus minigene/association analysis of exon-10 skipping and rs1800404\",\n      \"pmids\": [\"41443368\", \"40996958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether OCA2 transports additional ions or substrates beyond Cl- not excluded\", \"Structural basis of OCA2 Cl- conduction not yet resolved experimentally\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How OCA2's melanosomal Cl- channel function mechanistically connects to its pleiotropic roles in sleep and chemoresistance remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No mechanism linking ion transport to sleep regulation\", \"Drug-sequestration model for chemoresistance not directly tested\", \"No experimental high-resolution structure of OCA2\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 15, 20]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": []}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 2, 8]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [2, 10]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": []}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"TPCN2\", \"AP-3\", \"AP-1\", \"BLOC-1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}